CSL Ltd - Asset Resilience Ratio

Latest as of June 2024: 0.41%

CSL Ltd (CSL) has an Asset Resilience Ratio of 0.41% as of June 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

AU$157.48 Million

Cash + Short-term Investments

Total Assets

AU$38.02 Billion

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1997–2023)

This chart shows how CSL Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down CSL Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$157.48 Million	0.41%
Total Liquid Assets	AU$157.48 Million	0.41%

Asset Resilience Insights

Limited Liquidity: CSL Ltd maintains only 0.41% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

CSL Ltd Industry Peers by Asset Resilience Ratio

Compare CSL Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Argen-X F:1AE	Biotechnology	25.67%
ACRO Biomedical Co., Ltd. TWO:6748	Biotechnology	60.44%
Shenzhen CAU Technology Co Ltd SHE:000004	Biotechnology	6.20%
Pacific Shuanglin Bio pharmacy Co Ltd SHE:000403	Biotechnology	6.88%
Nanhua Bio Medicine Co Ltd SHE:000504	Biotechnology	11.93%
Jiangsu Sihuan Bioengineering Co Ltd SHE:000518	Biotechnology	0.03%
Chengzhi Shareholding Co Ltd SHE:000990	Biotechnology	6.73%
Hualan Biological EngineeringInc SHE:002007	Biotechnology	14.68%

Annual Asset Resilience Ratio for CSL Ltd (1997–2023)

The table below shows the annual Asset Resilience Ratio data for CSL Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-06-30	0.02%	AU$9.00 Million	AU$54.43 Billion	+0.01pp
2022-06-30	0.01%	AU$4.20 Million	AU$41.22 Billion	-0.01pp
2021-06-30	0.02%	AU$3.60 Million	AU$18.16 Billion	0.00pp
2020-06-30	0.02%	AU$3.30 Million	AU$15.46 Billion	+0.02pp
2019-06-30	0.00%	AU$279.62K	AU$12.27 Billion	-0.01pp
2018-06-30	0.01%	AU$1.18 Million	AU$10.73 Billion	-0.05pp
2017-06-30	0.06%	AU$5.20 Million	AU$9.12 Billion	+0.05pp
2016-06-30	0.01%	AU$601.19K	AU$7.58 Billion	-0.03pp
2015-06-30	0.04%	AU$1.98 Million	AU$4.87 Billion	+0.04pp
2014-06-30	0.00%	AU$300.00K	AU$6.28 Billion	0.00pp
2013-06-30	0.01%	AU$500.00K	AU$5.98 Billion	-0.02pp
2012-06-30	0.03%	AU$1.86 Million	AU$6.03 Billion	-0.32pp
2011-06-30	0.36%	AU$20.57 Million	AU$5.79 Billion	+0.35pp
2010-06-30	0.01%	AU$343.08K	AU$4.09 Billion	0.00pp
2009-06-30	0.01%	AU$550.99K	AU$4.75 Billion	-0.02pp
2008-06-30	0.03%	AU$1.45 Million	AU$4.49 Billion	+0.02pp
2007-06-30	0.01%	AU$426.98K	AU$3.02 Billion	-0.17pp
2006-06-30	0.19%	AU$4.31 Million	AU$2.29 Billion	-4.46pp
2002-06-30	4.64%	AU$60.45 Million	AU$1.30 Billion	-8.45pp
2001-06-30	13.10%	AU$60.87 Million	AU$464.77 Million	-30.45pp
2000-06-30	43.54%	AU$147.68 Million	AU$339.16 Million	+35.94pp
1999-06-30	7.60%	AU$18.95 Million	AU$249.27 Million	+0.12pp
1998-06-30	7.48%	AU$15.01 Million	AU$200.68 Million	-0.88pp
1997-06-30	8.36%	AU$32.21 Million	AU$385.18 Million	--

pp = percentage points

About CSL Ltd

AU:CSL Australia Biotechnology

Market Cap

$47.22 Billion

AU$66.73 Billion AUD

Market Cap Rank

#494 Global

#6 in Australia

Share Price

AU$137.55

Change (1 day)

-1.36%

52-Week Range

AU$134.62 - AU$272.00

All Time High

AU$321.70